 | • レポートコード：D0GIR-01117 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオシミラーモノクローナル抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオシミラーモノクローナル抗体の種類別市場規模（合成化学品、バイオ医薬品、その他）、用途別市場規模（慢性・自己免疫疾患、腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Biocon、3SBio、Amgen、Accord Healthcare、Hospira、AET Biotech、Alvartis、Reddy's Laboratories、Celltrion、Allergan ・地域別グローバル市場分析 2015年-2020年 ・バイオシミラーモノクローナル抗体の北米市場（アメリカ、カナダ、メキシコ） ・バイオシミラーモノクローナル抗体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオシミラーモノクローナル抗体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオシミラーモノクローナル抗体の南米市場（ブラジル、アルゼンチン） ・バイオシミラーモノクローナル抗体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：合成化学品、バイオ医薬品、その他 ・用途別分析：慢性・自己免疫疾患、腫瘍、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Biosimilar Monoclonal Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 26.5% in the forecast period of 2020 to 2025 and will expected to reach USD 12060 million by 2025, from USD 4706.7 million in 2019.
The Biosimilar Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimilar Monoclonal Antibody market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimilar Monoclonal Antibody market has been segmented into:
Synthetic Chemicals
Biopharmaceuticals
Others
By Application, Biosimilar Monoclonal Antibody has been segmented into:
Chronic & Autoimmune Diseases
Oncology
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilar Monoclonal Antibody market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilar Monoclonal Antibody markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilar Monoclonal Antibody market.
The report offers in-depth assessment of the growth and other aspects of the Biosimilar Monoclonal Antibody market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimilar Monoclonal Antibody Market Share Analysis
Biosimilar Monoclonal Antibody competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilar Monoclonal Antibody sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilar Monoclonal Antibody sales, revenue and market share for each player covered in this report.
The major players covered in Biosimilar Monoclonal Antibody are:
Biocon
3SBio
Amgen
Accord Healthcare
Hospira
AET Biotech
Alvartis
Reddy’s Laboratories
Celltrion
Allergan
Table of Contents
1 Biosimilar Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibody
1.2 Classification of Biosimilar Monoclonal Antibody by Type
1.2.1 Global Biosimilar Monoclonal Antibody Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Type in 2019
1.2.3 Synthetic Chemicals
1.2.4 Biopharmaceuticals
1.2.5 Others
1.3 Global Biosimilar Monoclonal Antibody Market by Application
1.3.1 Overview: Global Biosimilar Monoclonal Antibody Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chronic & Autoimmune Diseases
1.3.3 Oncology
1.3.4 Others
1.4 Global Biosimilar Monoclonal Antibody Market by Regions
1.4.1 Global Biosimilar Monoclonal Antibody Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biosimilar Monoclonal Antibody (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biosimilar Monoclonal Antibody Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biosimilar Monoclonal Antibody Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilar Monoclonal Antibody Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biosimilar Monoclonal Antibody Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilar Monoclonal Antibody Status and Prospect (2015-2025)
2 Company Profiles
2.1 Biocon
2.1.1 Biocon Details
2.1.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biocon SWOT Analysis
2.1.4 Biocon Product and Services
2.1.5 Biocon Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.2 3SBio
2.2.1 3SBio Details
2.2.2 3SBio Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 3SBio SWOT Analysis
2.2.4 3SBio Product and Services
2.2.5 3SBio Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.4 Accord Healthcare
2.4.1 Accord Healthcare Details
2.4.2 Accord Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Accord Healthcare SWOT Analysis
2.4.4 Accord Healthcare Product and Services
2.4.5 Accord Healthcare Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hospira
2.5.1 Hospira Details
2.5.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hospira SWOT Analysis
2.5.4 Hospira Product and Services
2.5.5 Hospira Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.6 AET Biotech
2.6.1 AET Biotech Details
2.6.2 AET Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AET Biotech SWOT Analysis
2.6.4 AET Biotech Product and Services
2.6.5 AET Biotech Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.7 Alvartis
2.7.1 Alvartis Details
2.7.2 Alvartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Alvartis SWOT Analysis
2.7.4 Alvartis Product and Services
2.7.5 Alvartis Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.8 Reddy’s Laboratories
2.8.1 Reddy’s Laboratories Details
2.8.2 Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Reddy’s Laboratories SWOT Analysis
2.8.4 Reddy’s Laboratories Product and Services
2.8.5 Reddy’s Laboratories Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.9 Celltrion
2.9.1 Celltrion Details
2.9.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Celltrion SWOT Analysis
2.9.4 Celltrion Product and Services
2.9.5 Celltrion Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
2.10 Allergan
2.10.1 Allergan Details
2.10.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Allergan SWOT Analysis
2.10.4 Allergan Product and Services
2.10.5 Allergan Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biosimilar Monoclonal Antibody Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimilar Monoclonal Antibody Players Market Share
3.2.2 Top 10 Biosimilar Monoclonal Antibody Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biosimilar Monoclonal Antibody Revenue and Market Share by Regions
4.2 North America Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.3 Europe Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.5 South America Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
5 North America Biosimilar Monoclonal Antibody Revenue by Countries
5.1 North America Biosimilar Monoclonal Antibody Revenue by Countries (2015-2020)
5.2 USA Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
5.3 Canada Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
5.4 Mexico Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6 Europe Biosimilar Monoclonal Antibody Revenue by Countries
6.1 Europe Biosimilar Monoclonal Antibody Revenue by Countries (2015-2020)
6.2 Germany Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.3 UK Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.4 France Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.5 Russia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
6.6 Italy Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Countries
7.1 Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Countries (2015-2020)
7.2 China Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.3 Japan Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.4 Korea Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.5 India Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
8 South America Biosimilar Monoclonal Antibody Revenue by Countries
8.1 South America Biosimilar Monoclonal Antibody Revenue by Countries (2015-2020)
8.2 Brazil Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
8.3 Argentina Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biosimilar Monoclonal Antibody by Countries
9.1 Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9.3 UAE Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9.4 Egypt Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
9.5 South Africa Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biosimilar Monoclonal Antibody Revenue and Market Share by Type (2015-2020)
10.2 Global Biosimilar Monoclonal Antibody Market Forecast by Type (2019-2024)
10.3 Synthetic Chemicals Revenue Growth Rate (2015-2025)
10.4 Biopharmaceuticals Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Biosimilar Monoclonal Antibody Market Segment by Application
11.1 Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2015-2020)
11.2 Biosimilar Monoclonal Antibody Market Forecast by Application (2019-2024)
11.3 Chronic & Autoimmune Diseases Revenue Growth (2015-2020)
11.4 Oncology Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Biosimilar Monoclonal Antibody Market Size Forecast (2021-2025)
12.1 Global Biosimilar Monoclonal Antibody Market Size Forecast (2021-2025)
12.2 Global Biosimilar Monoclonal Antibody Market Forecast by Regions (2021-2025)
12.3 North America Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.4 Europe Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.6 South America Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biosimilar Monoclonal Antibody Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilar Monoclonal Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilar Monoclonal Antibody Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biosimilar Monoclonal Antibody Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Biocon Corporate Information, Location and Competitors
Table 6. Biocon Biosimilar Monoclonal Antibody Major Business
Table 7. Biocon Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 8. Biocon SWOT Analysis
Table 9. Biocon Biosimilar Monoclonal Antibody Product and Solutions
Table 10. Biocon Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. 3SBio Corporate Information, Location and Competitors
Table 12. 3SBio Biosimilar Monoclonal Antibody Major Business
Table 13. 3SBio Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2018-2019)
Table 14. 3SBio SWOT Analysis
Table 15. 3SBio Biosimilar Monoclonal Antibody Product and Solutions
Table 16. 3SBio Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Amgen Corporate Information, Location and Competitors
Table 18. Amgen Biosimilar Monoclonal Antibody Major Business
Table 19. Amgen Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 20. Amgen SWOT Analysis
Table 21. Amgen Biosimilar Monoclonal Antibody Product and Solutions
Table 22. Amgen Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Accord Healthcare Corporate Information, Location and Competitors
Table 24. Accord Healthcare Biosimilar Monoclonal Antibody Major Business
Table 25. Accord Healthcare Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 26. Accord Healthcare SWOT Analysis
Table 27. Accord Healthcare Biosimilar Monoclonal Antibody Product and Solutions
Table 28. Accord Healthcare Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hospira Corporate Information, Location and Competitors
Table 30. Hospira Biosimilar Monoclonal Antibody Major Business
Table 31. Hospira Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 32. Hospira SWOT Analysis
Table 33. Hospira Biosimilar Monoclonal Antibody Product and Solutions
Table 34. Hospira Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AET Biotech Corporate Information, Location and Competitors
Table 36. AET Biotech Biosimilar Monoclonal Antibody Major Business
Table 37. AET Biotech Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 38. AET Biotech SWOT Analysis
Table 39. AET Biotech Biosimilar Monoclonal Antibody Product and Solutions
Table 40. AET Biotech Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Alvartis Corporate Information, Location and Competitors
Table 42. Alvartis Biosimilar Monoclonal Antibody Major Business
Table 43. Alvartis Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 44. Alvartis SWOT Analysis
Table 45. Alvartis Biosimilar Monoclonal Antibody Product and Solutions
Table 46. Alvartis Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Reddy's Laboratories Corporate Information, Location and Competitors
Table 48. Reddy's Laboratories Biosimilar Monoclonal Antibody Major Business
Table 49. Reddy's Laboratories Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 50. Reddy's Laboratories SWOT Analysis
Table 51. Reddy's Laboratories Biosimilar Monoclonal Antibody Product and Solutions
Table 52. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Celltrion Corporate Information, Location and Competitors
Table 54. Celltrion Biosimilar Monoclonal Antibody Major Business
Table 55. Celltrion Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 56. Celltrion SWOT Analysis
Table 57. Celltrion Biosimilar Monoclonal Antibody Product and Solutions
Table 58. Celltrion Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Allergan Corporate Information, Location and Competitors
Table 60. Allergan Biosimilar Monoclonal Antibody Major Business
Table 61. Allergan Biosimilar Monoclonal Antibody Total Revenue (USD Million) (2017-2018)
Table 62. Allergan SWOT Analysis
Table 63. Allergan Biosimilar Monoclonal Antibody Product and Solutions
Table 64. Allergan Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Biosimilar Monoclonal Antibody Revenue (Million USD) by Players (2015-2020)
Table 66. Global Biosimilar Monoclonal Antibody Revenue Share by Players (2015-2020)
Table 67. Global Biosimilar Monoclonal Antibody Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Biosimilar Monoclonal Antibody Revenue Market Share by Regions (2015-2020)
Table 69. North America Biosimilar Monoclonal Antibody Revenue by Countries (2015-2020)
Table 70. North America Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Table 71. Europe Biosimilar Monoclonal Antibody Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Biosimilar Monoclonal Antibody Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Biosimilar Monoclonal Antibody Revenue by Countries (2015-2020)
Table 74. South America Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Biosimilar Monoclonal Antibody Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Table 77. Global Biosimilar Monoclonal Antibody Revenue (Million USD) by Type (2015-2020)
Table 78. Global Biosimilar Monoclonal Antibody Revenue Share by Type (2015-2020)
Table 79. Global Biosimilar Monoclonal Antibody Revenue Forecast by Type (2021-2025)
Table 80. Global Biosimilar Monoclonal Antibody Revenue by Application (2015-2020)
Table 81. Global Biosimilar Monoclonal Antibody Revenue Share by Application (2015-2020)
Table 82. Global Biosimilar Monoclonal Antibody Revenue Forecast by Application (2021-2025)
Table 83. Global Biosimilar Monoclonal Antibody Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biosimilar Monoclonal Antibody Picture
Figure 2. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type in 2019
Figure 3. Synthetic Chemicals Picture
Figure 4. Biopharmaceuticals Picture
Figure 5. Others Picture
Figure 6. Biosimilar Monoclonal Antibody Revenue Market Share by Application in 2019
Figure 7. Chronic & Autoimmune Diseases Picture
Figure 8. Oncology Picture
Figure 9. Others Picture
Figure 10. Global Biosimilar Monoclonal Antibody Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biosimilar Monoclonal Antibody Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Biosimilar Monoclonal Antibody Revenue Market Share in 2019
Figure 19. Global Top 10 Players Biosimilar Monoclonal Antibody Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Biosimilar Monoclonal Antibody Revenue Market Share by Regions (2015-2020)
Figure 23. Global Biosimilar Monoclonal Antibody Revenue Market Share by Regions in 2018
Figure 24. North America Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 25. Europe Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 27. South America Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 29. North America Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 30. North America Biosimilar Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 31. USA Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 32. Canada Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 34. Europe Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Biosimilar Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 36. Germany Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 37. UK Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 38. France Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 39. Russia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 40. Italy Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Biosimilar Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 43. China Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 44. Japan Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 45. Korea Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 46. India Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 48. South America Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 49. South America Biosimilar Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 50. Brazil Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Biosimilar Monoclonal Antibody Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Biosimilar Monoclonal Antibody Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 55. UAE Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Biosimilar Monoclonal Antibody Revenue and Growth Rate (2015-2020)
Figure 58. Global Biosimilar Monoclonal Antibody Revenue Share by Type (2015-2020)
Figure 59. Global Biosimilar Monoclonal Antibody Revenue Share by Type in 2019
Figure 60. Global Biosimilar Monoclonal Antibody Market Share Forecast by Type (2021-2025)
Figure 61. Global Synthetic Chemicals Revenue Growth Rate (2015-2020)
Figure 62. Global Biopharmaceuticals Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Biosimilar Monoclonal Antibody Revenue Share by Application (2015-2020)
Figure 65. Global Biosimilar Monoclonal Antibody Revenue Share by Application in 2019
Figure 66. Global Biosimilar Monoclonal Antibody Market Share Forecast by Application (2021-2025)
Figure 67. Global Chronic & Autoimmune Diseases Revenue Growth Rate (2015-2020)
Figure 68. Global Oncology Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Biosimilar Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Biosimilar Monoclonal Antibody Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Biosimilar Monoclonal Antibody Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 74. Europe Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 76. South America Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Biosimilar Monoclonal Antibody Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
狂犬病モノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rabies Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…- 次世代抗体治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Next Generation Antibody Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Next Ge…
- バイオシミラー試験・開発サービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Biosimilar Testing and Development Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The B…
- CD38モノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The CD38 Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- モノクローナル抗体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Monoclonal Antibodies m…